Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantum Genesis AI (QTZM) Notes Payables (2024 - 2026)

Quantumzyme's Notes Payables history spans 3 years, with the latest figure at $232066.0 for Q1 2026.

  • For Q1 2026, Notes Payables changed N/A year-over-year to $232066.0; the TTM value through Jan 2026 reached $232066.0, changed N/A, while the annual FY2025 figure was $249081.0, 48.56% up from the prior year.
  • Notes Payables reached $232066.0 in Q1 2026 per QTZM's latest filing, down from $268594.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $268594.0 in Q4 2025 to a low of $167666.0 in Q3 2024.
  • Average Notes Payables over 3 years is $231571.6, with a median of $240451.0 recorded in 2025.
  • The largest YoY upside for Notes Payables was 48.56% in 2025 against a maximum downside of 48.56% in 2025.
  • A 3-year view of Notes Payables shows it stood at $167666.0 in 2024, then skyrocketed by 60.2% to $268594.0 in 2025, then fell by 13.6% to $232066.0 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's Notes Payables are $232066.0 (Q1 2026), $268594.0 (Q4 2025), and $249081.0 (Q3 2025).